AVDL
Avadel Pharm Sp ADR

3,423
Mkt Cap
$2.11B
Volume
200.00
52W High
$23.57
52W Low
$6.38
PE Ratio
-3,934.55
AVDL Fundamentals
Price
$21.64
Prev Close
$21.63
Open
$21.66
50D MA
$21.53
Beta
0.72
Avg. Volume
1.54M
EPS (Annual)
-$0.5133
P/B
21.42
Rev/Employee
$899,558.51
$963.11
Loading...
Loading...

About

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
188

Frequently Asked Questions

What is Market Cap of Avadel Pharmaceuticals plc?
What is the 52-week high for Avadel Pharmaceuticals plc?
What is the 52-week low for Avadel Pharmaceuticals plc?
What is Avadel Pharmaceuticals plc stock price today?
What was Avadel Pharmaceuticals plc stock price yesterday?
What is the PE ratio of Avadel Pharmaceuticals plc?
What is the Price-to-Book ratio of Avadel Pharmaceuticals plc?
What is the 50-day moving average of Avadel Pharmaceuticals plc?
How many employees does Avadel Pharmaceuticals plc have?

Latest AVDL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.